These results are in good agreement with ApoA-I variants preferential tissue accumulation and with the ectopic localization of the selected ECM components, suggesting that the extracellular environment contributes to the different types of clinical manifestations of ApoA-I amyloidosis. This evidence concerns the gene APOA1 and amyloidosis.